Baillie Gifford & CO Tandem Diabetes Care Inc Transaction History
Baillie Gifford & CO
- $127 Billion
- Q4 2024
A detailed history of Baillie Gifford & CO transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Baillie Gifford & CO holds 746,109 shares of TNDM stock, worth $23.1 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
746,109
Previous 222,266
235.68%
Holding current value
$23.1 Million
Previous $9.42 Million
185.17%
% of portfolio
0.02%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding TNDM
# of Institutions
346Shares Held
70.9MCall Options Held
3.11MPut Options Held
181K-
Black Rock Inc. New York, NY11.1MShares$345 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.44MShares$231 Million0.0% of portfolio
-
State Street Corp Boston, MA2.77MShares$85.7 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.72MShares$84.4 Million1.47% of portfolio
-
Gw&K Investment Management, LLC Boston, MA2.12MShares$65.8 Million0.65% of portfolio
About TANDEM DIABETES CARE INC
- Ticker TNDM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 64,221,200
- Market Cap $1.99B
- Description
- Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...